Coronavirus disease 2019 and the pancreas
Copyright © 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved..
Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to a world-wide pandemic since its onset in December of 2019. Although, a primary respiratory pathogen, over the ensuing period, its extra-pulmonary effects have come to the forefront. The virus, having multi-organ tropism, has been shown to affect a host of other organs beyond the lung, including the pancreas. The data on pancreatic involvement by COVID-19, however, have been limited. Moreover, whether the effects on the pancreas are due to the direct effects of the virus or is just an epi-phenomenon is debatable. The prevalence of pancreatic injury and degree of injury are the other issues that need to be addressed. Pancreatic cancer has a dismal prognosis and the management of the same in the COVID era needs to be tailored assessing the risk-benefit ratio for the same. Additionally, pancreatic surgery increases not only the morbidity of the patient, but also the risk of the operator and burden on the health care system. Hence, the decision for such major procedures needs to be rationalized for optimum benefit during this pandemic. Similarly, for the endoscopist, pancreatic endoscopy needs to be carefully regulated to reduce risk to both the patient and the physician and yet deliver optimum patient care. This review gives a concise summary of various aspects of pancreatic involvement and pancreatic disease management during this pandemic.
| Errataetall: |
CommentIn: Rev Esp Enferm Dig. 2021 May;113(5):389. - PMID 33569964 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. - 20(2020), 8 vom: 30. Dez., Seite 1567-1575 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Samanta, Jayanta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 22.12.2020 Date Revised 04.06.2021 published: Print-Electronic CommentIn: Rev Esp Enferm Dig. 2021 May;113(5):389. - PMID 33569964 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.pan.2020.10.035 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318164868 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318164868 | ||
| 003 | DE-627 | ||
| 005 | 20231225164802.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pan.2020.10.035 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318164868 | ||
| 035 | |a (NLM)33250089 | ||
| 035 | |a (PII)S1424-3903(20)30785-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Samanta, Jayanta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Coronavirus disease 2019 and the pancreas |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.2020 | ||
| 500 | |a Date Revised 04.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Rev Esp Enferm Dig. 2021 May;113(5):389. - PMID 33569964 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has led to a world-wide pandemic since its onset in December of 2019. Although, a primary respiratory pathogen, over the ensuing period, its extra-pulmonary effects have come to the forefront. The virus, having multi-organ tropism, has been shown to affect a host of other organs beyond the lung, including the pancreas. The data on pancreatic involvement by COVID-19, however, have been limited. Moreover, whether the effects on the pancreas are due to the direct effects of the virus or is just an epi-phenomenon is debatable. The prevalence of pancreatic injury and degree of injury are the other issues that need to be addressed. Pancreatic cancer has a dismal prognosis and the management of the same in the COVID era needs to be tailored assessing the risk-benefit ratio for the same. Additionally, pancreatic surgery increases not only the morbidity of the patient, but also the risk of the operator and burden on the health care system. Hence, the decision for such major procedures needs to be rationalized for optimum benefit during this pandemic. Similarly, for the endoscopist, pancreatic endoscopy needs to be carefully regulated to reduce risk to both the patient and the physician and yet deliver optimum patient care. This review gives a concise summary of various aspects of pancreatic involvement and pancreatic disease management during this pandemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Pancreatic carcinoma | |
| 650 | 4 | |a Pancreatic transplant | |
| 650 | 4 | |a Pancreatitis | |
| 700 | 1 | |a Gupta, Rohit |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Mini P |e verfasserin |4 aut | |
| 700 | 1 | |a Patnaik, Itish |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Ashok |e verfasserin |4 aut | |
| 700 | 1 | |a Kochhar, Rakesh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. |d 2001 |g 20(2020), 8 vom: 30. Dez., Seite 1567-1575 |w (DE-627)NLM119887509 |x 1424-3911 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2020 |g number:8 |g day:30 |g month:12 |g pages:1567-1575 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pan.2020.10.035 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2020 |e 8 |b 30 |c 12 |h 1567-1575 | ||